Litcius/Paper detail

Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma

Ruiqi Wu, Xiang‐Ming Lao, Dong‐Ping Chen, Hongqiang Qin, Ming Mu, Wen-Jie Cao, Jia Deng, Chao-Chao Wan, Wan-Yu Zhan, Juncheng Wang, Li Xu, Minshan Chen, Qiang Gao, Limin Zheng, Wei Yuan, Dong‐Ming Kuang

2022Immunity74 citationsDOI

Topics & Concepts

Immune checkpointAntibodyImmunologyImmune systemImmunotherapyBiologyImmunityCancer researchBlockadeInterferonImmunoglobulin GReceptorBiochemistryImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersImmune cells in cancer
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma | Litcius